Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 110 of 200 · By data quality, then INN

  1. tolcapone

    TASMAR

    ORAL FDA: approved · EMA: approved

    N04BX01

  2. tolmetin sodium

    TOLECTIN DS

    ORAL FDA: approved

  3. tolvaptan

    JINARC Otsuka Beijing Research Institute

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    C03XA01

  4. topotecan hydrochloride

    TOPOTECAN HYDROCHLORIDE

    ORAL FDA: approved

  5. toremifene citrate

    TOREMIFENE CITRATE

    ORAL FDA: approved

  6. tovorafenib

    OJEMDA

    ORAL FDA: approved · EMA: approved

    L01EC04

  7. trabectedin

    YONDELIS Lacuna Pharma Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01CX01

  8. tralokinumab

    ADTRALZA

    INJECTION FDA: approved · EMA: approved

    D11

  9. trametinib

    MEKINIST Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01EE01

  10. trametinib dimethyl sulfoxide

    MEKINIST INITIAL APPROVAL

    ORAL FDA: approved · PMDA: approved

  11. tranylcypromine sulfate

    TRANYLCYPROMINE SULFATE

    ORAL FDA: approved

  12. trastuzumab

    HERZUMA Pfizer Australia Pty Ltd

    INTRAVENOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FD01

  13. trastuzumab and hyaluronidase-oysk

    HERCEPTIN HYLECTA

    SUBCUTANEOUS FDA: approved

  14. trastuzumab-anns

    KANJINTI

    SINGLE-DOSE FDA: approved

  15. trastuzumab-dkst

    OGIVRI

    INJECTION FDA: approved

  16. trastuzumab-dttb

    ONTRUZANT

    IV (INFUSION) FDA: approved

  17. trastuzumab-pkrb

    HERZUMA

    INJECTION FDA: approved

  18. trastuzumab-qyyp

    TRAZIMERA

    INJECTION FDA: approved

  19. trastuzumab-strf

    HERCESSI

    INJECTION FDA: approved

  20. travoprost

    TRAVATAN Novartis Pharmaceuticals

    OPHTHALMIC FDA: approved · EMA: approved · TGA: approved

    S01ED51

  21. tremelimumab-actl

    IMJUDO

    INTRAVENOUS FDA: approved

  22. treosulfan

    TRECONDI

    INTRAVENOUS FDA: approved · EMA: approved

    L01AB02

  23. triamcinolone diacetate

    TRIAMCINOLONE DIACETATE

    INJECTION FDA: approved

  24. triamcinolone hexacetonide

    ARISTOSPAN

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.